28 Jul, 2023 09:26 AM
Highlights:
-- Positive clinical data demonstrating SubB2M/CA15-3 test detects all-stages of breast cancer with excellent accuracy (87%), sensitivity (81%) and specificity (93%)
-- Post quarter ...read more
06 Jul, 2023 08:32 AM
Melbourne, Australia and Madison, WI USA, 6 July 2023: INOVIQ Limited (ASX:IIQ) (INOVIQ), an innovative developer of exosome solutions and precision diagnostics, and Promega Corporation (Promega), a...read more
13 Dec, 2022 09:46 AM
-- EXO-NET® feasibility study completed by The University of Queensland, confirms the utility of EXO-NET for isolating Extracellular Vesicle (EV) biomarkers and development of an EV-based ovaria...read more
05 Dec, 2022 10:34 AM
Melbourne, Australia, 5 December 2022: INOVIQLimited (ASX:IIQ) (INOVIQ or the Company) advises that CEO Dr Leearne Hinch will deliver the attached presentation to investors and shareholders at&...read more